Loading...

iAnthus Capital Holdings, Inc.

IAN.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.01
CA$0.005(100.00%)

iAnthus Capital Holdings, Inc. (IAN.CN) Stock Overview

Explore iAnthus Capital Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap33.7M
P/E Ratio-3.17
EPS (TTM)$-0.01
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Week$0.01
1 Month$0.01
3 Months$0.00
1 Year Target$0.01

IAN.CN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of iAnthus Capital Holdings, Inc. (IAN.CN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.17 and a market capitalization of 33.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
5.23%
↑ 5.23%
Profit Growth
CA$-0.00
↑ 90.03%
EPS Growth
CA$-0.00
↑ 89.92%
Operating Margin
-5.94%
↑ 79.09%
ROE
9.62%
↑ 90.03%
Dividend Yield
0.00%
Analyst Recommendations data is not available for IAN.CNAnalyst Recommendations details for IAN.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.

CEO

Richard Proud

Employees

716

Headquarters

420 Lexington Avenue, Toronto, NY

Founded

2016

Frequently Asked Questions

;